You are here

Merck

Endocyte Doubles on Ovarian Drug Partnership With Merck

Bloomberg

Mon, 04/16/12 - 11:28 am

More Hair, Less Reason for It

Motley Fool

Sat, 04/14/12 - 12:42 pm

sexual dysfunction

Ample Supplies of Shingles Vaccine Return

WSJ

Sat, 04/14/12 - 12:38 pm

Are Merck’s Top Investors Waiting for Catalysts to Bid Shares Higher in 2012?

Wall St. Cheat Sheet

Sat, 04/14/12 - 12:37 pm

Sexual side effect warnings added to Merck drugs

Reuters

Thu, 04/12/12 - 11:28 am

enlarged prostate

Valeant Headed Into High Growth Phase

Seeking Alpha

Wed, 04/11/12 - 09:33 am

Valeant Pharmaceuticals

Vaccines group gets cut-price GSK, Merck rotavirus shots

Reuters

Tue, 04/10/12 - 09:29 am

Merck Can Sue State For Outsourcing Vioxx Lawsuits

Pharmalot

Mon, 04/9/12 - 12:10 pm

Novo Nordisk says diabetes drug Victoza superior to Merck rival

Reuters

Sat, 04/7/12 - 11:56 am

Lpath: A Solid Pipeline With Good PPS

Seeking Alpha

Thu, 04/5/12 - 07:38 pm

bioactive lipids

Vaccines alliance nears deal on cervical cancer shots

Reuters

Wed, 04/4/12 - 10:58 pm

cervical cancer

Pfizer: A Compelling Buy Candidate In 2012

Seeking Alpha

Wed, 04/4/12 - 10:56 pm

Abbott Laboratories

Bristol-Myers Squibb

Mead Johnson Nutrition

Merck: High Upside Expected From Vaccine

Seeking Alpha

Wed, 04/4/12 - 08:32 am

Merck: Now A Compelling 'Buy' Candidate

Seeking Alpha

Mon, 04/2/12 - 11:58 am

Are Ariad's Options Dwindling?

Motley Fool

Sun, 04/1/12 - 12:35 pm

Ariad Pharmaceuticals

Big Pharma Cozies Up to Biotech

Motley Fool

Sat, 03/31/12 - 12:20 pm

Abbott: Expect Strong Upside Movement, Both Pre And Post Research Division Spin-Off

Seeking Alpha

Thu, 03/29/12 - 11:58 am

Abbott Laboratories

Watson Pharmaceuticals

Mixed Data on Merck's Vorapaxar

Yahoo/Zacks.com

Wed, 03/28/12 - 04:14 pm

Merck says key Vytorin study cleared to continue

Reuters

Wed, 03/28/12 - 10:12 am

Merck Blood Thinner Stops Heart Attacks With Risk of Bleeding

Bloomberg

Sat, 03/24/12 - 11:47 am

Pages